Klearchos K. Papas

Sep 3, 2024 | nature.com | Alessandro Grattoni |Andres Garcia |Andrés García |Andrew R. Pepper |Michael A Brehm |Klearchos K. Papas | +9 more

AbstractType 1 diabetes mellitus (T1DM) is a growing global health concern that affects approximately 8.5 million individuals worldwide. T1DM is characterized by an autoimmune destruction of pancreatic β cells, leading to a disruption in glucose homeostasis. Therapeutic intervention for T1DM requires a complex regimen of glycaemic monitoring and the administration of exogenous insulin to regulate blood glucose levels.